题名 | Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial |
链接 | https://pubmed.ncbi.nlm.nih.gov/37778358/ |
https://pubmed.ncbi.nlm.nih.gov/37778358/
欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |